RIGI and cancer: RIG-I is ubiquitously expressed in non-malignant but also malignant cells and leads not only to the release of antiviral cytokines (e.g. type I IFN) and NK cell activation but also to apoptosis induction in cancer but not in non-malignant cells [7–11].